Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
CDC-recommended first-line tests for pertussis are Bordetella pertussis/parapertussis by PCR (0065080) and/or Bordetella pertussis Culture (0060117). However, if serology is used to assess late-stage pertussis (>4 weeks), this is the recommended test.
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL) Parallel testing is preferred, and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as "acute" or "convalescent."
Contaminated, heat-inactivated, or severely lipemic specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
B. pertussis Ab, IgA by ELISA
Bordetella pertussis Antibody, IgA by ELISA
Effective February 20, 2018 0.9 IV or less: Negative - No significant level of detectable Bordetella pertussis IgA antibody. 1.0-1.1 IV: Equivocal - Repeat testing in 10-14 days may be helpful. 1.2 IV or greater: Positive - IgA antibody to Bordetella pertussis detected, which may indicate a current or past exposure/immunization to B. pertussis.
Bordetella pertussis Antibody, IgG by ELISA with Reflex to Immunoblot
Bordetella pertussis Antibody IgG by ELISA
Effective February 20, 2018 0.94 IV or less: Negative - No significant level of detectable B. pertussis IgG antibody. 0.95-1.04 IV: Equivocal - Repeat testing in 10-14 days may be helpful. 1.05 IV or greater: Positive - IgG antibody to B. pertussis detected, which may indicate a current or recent exposure/immunization to B. pertussis.
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Refer to report.
Laboratory Developed Test (LDT)
NoteAdditional information related to the test.
If Bordetella pertussis Antibody, IgA by ELISA is 1.2 IV or greater, then Bordetella pertussis IgA Immunoblot testing will be added; if Bordetella pertussis Antibody, IgG by ELISA is 1.05 IV or greater, then Bordetella pertussis IgG Immunoblot testing will be added. Additional charges apply.
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
86615 x2; if reflexed, add 86615 for each Immunoblot
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.
B. pertussis Abs panel reflex
Pertussis IgA and IgG Abs reflex to immunoblot
Bordetella pertussis Antibodies, IgA and IgG by ELISA with Reflex to Immunoblot